Initial evaluation of hepatic T1 relaxation time as an imaging marker of liver disease associated with autosomal recessive polycystic kidney disease (ARPKD).

MLA

Gao, Ying, et al. “Initial Evaluation of Hepatic T1 Relaxation Time as an Imaging Marker of Liver Disease Associated with Autosomal Recessive Polycystic Kidney Disease (ARPKD).” NMR in Biomedicine, vol. 29, no. 1, Jan. 2016, pp. 84–89. EBSCOhost, https://doi.org/10.1002/nbm.3442.

APA

Gao, Y., Erokwu, B. O., DeSantis, D. A., Croniger, C. M., Schur, R. M., Lu, L., Mariappuram, J., Dell, K. M., & Flask, C. A. (2016). Initial evaluation of hepatic T1 relaxation time as an imaging marker of liver disease associated with autosomal recessive polycystic kidney disease (ARPKD). NMR in Biomedicine, 29(1), 84–89. https://doi.org/10.1002/nbm.3442

Chicago

Gao, Ying, Bernadette O. Erokwu, David A. DeSantis, Colleen M. Croniger, Rebecca M. Schur, Lan Lu, Jose Mariappuram, Katherine M. Dell, and Chris A. Flask. 2016. “Initial Evaluation of Hepatic T1 Relaxation Time as an Imaging Marker of Liver Disease Associated with Autosomal Recessive Polycystic Kidney Disease (ARPKD).” NMR in Biomedicine 29 (1): 84–89. doi:10.1002/nbm.3442.